Electrocardiographic screening in psychiatric patients

The role of electrocardiographic screening in psychiatric patients remains unclear due to inconsistent clinical guidelines. While cardiovascular risks are well-documented in general populations, psychiatric patients often present unique challenges in risk stratification. Prior research has shown that routine ECG screening is standard in many clinical settings. However, specific data on psychiatric inpatients remain limited. No prior work had resolved whether such screening is broadly beneficial in this group. This uncertainty drove the need for a focused study on psychiatric inpatient populations. The study aimed to clarify the frequency and significance of ECG abnormalities in this setting. It was already known that psychiatric patients may have altered drug exposure and comorbid conditions. This gap motivated an investigation into the utility of ECG screening in this specific patient group.

This study aimed to evaluate the clinical utility of routine ECG screening in psychiatric inpatients. The specific problem addressed was the lack of consensus on whether such screening is necessary for this population. The motivation stemmed from the potential for drug-induced cardiac effects and undiagnosed cardiovascular conditions. The researchers sought to determine how often ECG abnormalities occur in psychiatric patients. They also aimed to identify which patient groups benefit most from screening. No prior work had resolved the age-related differences in abnormal ECG findings. The study focused on a 2-year inpatient cohort at a psychiatric hospital. The goal was to inform clinical decision-making regarding ECG use in psychiatric care.

The study involved 1006 consecutive psychiatric inpatient admissions over two years at a public hospital. Each patient received a 12-lead ECG as part of routine screening. ECG tracings were categorized as normal, equivocal, or abnormal. Equivocal findings were primarily due to nonspecific T wave changes. Researchers also documented drug use and comorbid conditions contributing to ECG changes. Age distribution was analyzed to assess patterns of abnormal findings. Drug-related causes were specifically evaluated for T wave abnormalities. The study focused on identifying clinically significant ECG findings. Data were collected systematically and analyzed for trends in abnormality prevalence.

Out of 1006 ECGs, 765 were classified as normal. A total of 148 tracings were equivocal, with 118 showing nonspecific T wave abnormalities. Among these, 29 had no clear cause for the T wave changes. Drug abuse was identified as a cause in 80 cases, with cocaine and alcohol being most common. Subclinical hypothyroidism was found in 5 patients and borderline hypokalemia in 4. Ninety-three tracings were definitely abnormal, with half in patients over 50 years old. Only 5 of 162 ECGs in patients under 20 were abnormal. One abnormality in a young patient could have been clinically relevant if certain drugs were used. The overall rate of significant ECG findings was low except in older patients.

The study found that routine ECG screening in psychiatric patients yielded few clinically significant abnormalities. Most abnormalities were drug-related or age-related. The authors proposed that screening is most valuable for patients over 50 years old. They suggested that ECGs are indicated when cardiovascular risk factors are present. The researchers emphasized drug-related cardiac effects as a key finding. The prevalence of abnormalities was sufficient to support routine screening in older patients. They proposed that ECG use should be guided by clinical context and drug exposure. The authors did not suggest universal screening for all psychiatric patients. Their findings align with general population trends in ECG screening utility.